Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
JCSE01 - Perspectives for Lung Cancer Early Detection
- 07:30 - 11:15
- 9/23/2018
- Location: Room 202 BD
- Type: Joint IASLC/CSCO/CAALC Session
- Track: Screening and Early Detection
-
+
JCSE01.22 - Differential Molecular Mechanisms Associated with Dramatic and Gradual Progression in NSCLC Patients with Intrathoracic Dissemination
11:15 - 11:15 | Presenter: Ying Chen | Author(s): Bao Hua, Wei Li, Chao Zhang, Wen-Fang Tang, Ao Wang, Xue Wu, Jing-Hua Chen, Jian Su, Yang W. Shao, Yi-Long Wu, Wen-Zhao Zhong
- Abstract
Loading... -
+
JCSE01.22a - Tislelizumab Combined With Chemotherapy as First-Line Treatment in Chinese Patients With Advanced Lung Cancer
11:15 - 11:15 | Presenter: Jie Wang | Author(s): Jun Zhao, Zhijie Wang, Zhiyong Ma, Jiuwei Cui, Yongqian Shu, Zhe Liu, Ying Cheng, Shiang Jiin Leaw, Jian Li, Fan Xia
- Abstract
No abstract available for this presentation
-
+
P1.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.01-107 - The Impact of Anlotinib on Quality of Life in Patients with Advance NSCLC: Post-Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303)
16:45 - 18:00 | Presenter: Li Zhang | Author(s): Xiaoyan Si, Hanping Wang, Xiaotong Zhang, Mengzhao Wang, Baohui Han, Kai Li, Qiming Wang, Jianhua Shi, Zhehai Wang, Ying Cheng, Jianxing He, Yuankai Shi, Weiqiang Chen, Xiuwen Wang, Yi Luo, Kejun Nan, Faguang Jin, Baolan Li, Yinlan Chen, Jianying Zhou, Donglin Wang
- Abstract
Loading... -
+
P1.01-108 - Management of Anlotinib-Related Adverse Events: Data From ALTER 0303
16:45 - 18:00 | Presenter: Li Zhang | Author(s): Xiaoyan Si, Hanping Wang, Xiaotong Zhang, Mengzhao Wang, Baohui Han, Kai Li, Qiming Wang, Jianhua Shi, Zhehai Wang, Ying Cheng, Jianxing He, Yuankai Shi, Weiqiang Chen, Xiuwen Wang, Yi Luo, Kejun Nan, Faguang Jin, Baolan Li, Yinlan Chen, Jianying Zhou, Donglin Wang
- Abstract
Loading... -
+
P1.01-112 - Osimertinib vs Standard of Care (SoC) EGFR-TKI as First-Line Treatment in Chinese Patients With EGFRm Advanced NSCLC
16:45 - 18:00 | Presenter: Caicun Zhou | Author(s): Ying Cheng, Yong He, Wei Li, Helong Zhang, Qing Zhou, Buhai Wang, Chunling Liu, Suresh S. Ramalingam, Andrew Walding, Matilde Saggese, Jia Wang, Minhao Fan, Yi-Long Wu
- Abstract
Loading... -
+
P1.01-98 - A Phase IIIb Trial of Afatinib in EGFRm+ NSCLC: Analyses of Outcomes in Patients with Brain Metastases or Dose Reductions
16:45 - 18:00 | Presenter: Yi-Long Wu | Author(s): Haiyan Tu, Jifeng Feng, Meiqi Shi, Jun Zhao, Yuyan Wang, Jianhua Chang, Jialei Wang, Ying Cheng, Jing Zhu, Eng-Huat Tan, Kai Li, Yi Ping Zhang, Victor Lee, Cheng-Ta Yang, Wu-Chou Su, David Chi-Leung Lam, BJ Srinivasa, Senthil Rajappa, Ching-Liang Ho, Kwok Chi Lam, Yi Hu, Shailesh Arjun Bondarde, Xiaoqing Liu, Dennis Chin-Lun Huang, Yu Wang, Kaimin Pang, Caicun Zhou
- Abstract
Loading...
-
+
P1.04 - Immunooncology (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.04-36 - Tislelizumab Combined With Chemotherapy as First-Line Treatment in Chinese Patients With Advanced Lung Cancer
16:45 - 18:00 | Presenter: Jie Wang | Author(s): Jun Zhao, Zhijie Wang, Zhiyong Ma, Jiuwei Cui, Yongqian Shu, Zhe Liu, Ying Cheng, Shiang Jiin Leaw, Jian Li, Fan Xia
- Abstract
Loading...
-
+
MA10 - Considerations in Immunotherapy / Real World
- 10:30 - 12:00
- 9/25/2018
- Location: Room 105
- Type: Mini Oral Abstract Session
- Track: Advanced NSCLC
-
+
MA10.08 - Choice of Taxane and Outcomes in the KEYNOTE-407 Study of Pembrolizumab Plus Chemotherapy for Metastatic Squamous NSCLC
11:25 - 11:30 | Presenter: Balazs Halmos | Author(s): Alexander V Luft, Margarita Majem, Rina Hui, Romain Corre, Mahmut Gümüş, Konstantin Laktionov, Barbara Hermes, İrfan Çiçin, Andrew G Robinson, Terufumi Kato, Ying Cheng, Dariusz Kowalski, Xiaodong Li, Gregory M Lubiniecki, Bilal Piperdi, Luis Paz-Ares
- Abstract
Loading...
-
+
MA14 - Survivorship, Socioeconomic and End-of-Life Considerations
- 10:30 - 12:00
- 9/25/2018
- Location: Room 205 BD
- Type: Mini Oral Abstract Session
- Track: Treatment in the Real World - Support, Survivorship, Systems Research
-
+
MA14.09 - Mortality of Lung Cancer as a Second Primary Malignancy among Cancer Survivors: A Study of Surveillance, Epidemiology, and End Results Database
11:30 - 11:35 | Presenter: Lei Deng | Author(s): Huan Song, Zhengrui Xiao, Changchuan Jiang, Qian Wang, Haiying Cheng, Donghao Lu
- Abstract
Loading...
-
+
OA10 - Right Patient, Right Target & Right Drug - Novel Treatments and Research Partnerships
- 10:30 - 12:00
- 9/25/2018
- Location: Room 106
- Type: Oral Abstract Session
- Track: Targeted Therapy
-
+
OA10.07 - Resistance Mechanisms of Osimertinib in Chinese Non-Small Cell Lung Cancer Patients: Analysis from AURA17 Trial
11:35 - 11:45 | Presenter: Caicun Zhou | Author(s): Min Hu, Xuehua Zhu, Yun Sun, Xuesong Lu, Jia Wang, Mengzhao Wang, Ying Cheng, Yuan Chen, Yanqiu Zhao, Yuan-Kai Shi, You Lu, Meiqi Shi, He-Long Zhang, Xiangning Huang, Zheng Wang, Zhijie Ding, Heyan Li, George Chen, Yi-Long Wu
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.01-101 - Dynamic Monitoring of Gene Alterations with ctDNA by NGS for EGFR Mutated Lung Adenocarcinoma Treated with Gefitinib in BENEFIT Study (CTONG 1405)
16:45 - 18:00 | Presenter: Jie Wang | Author(s): Jian-Chun Duan, Shuhang Wang, Zhi-Jie Wang, Hua Bai, Jun Zhao, Hongjun Gao, Ying Cheng
- Abstract
Loading... -
+
P2.01-18 - Differential Molecular Mechanisms Associated with Dramatic and Gradual Progression in NSCLC Patients with Intrathoracic Dissemination
16:45 - 18:00 | Presenter: Ying Chen | Author(s): Bao Hua, Wei Li, Chao Zhang, Wen-Fang Tang, Ao Wang, Xue Wu, Jing-Hua Chen, Jian Su, Yang W. Shao, Yi-Long Wu, Wen-Zhao Zhong
- Abstract
Loading... -
+
P2.01-39 - Can Benefit or Futility in Treating Advanced Nsclc Be Determined Early Using the LCSS 3-Item Global Index (3-IGI) PRO?
16:45 - 18:00 | Presenter: Richard J Gralla | Author(s): Patricia J. Hollen, Richard Hall, Ryan Gentzler, Haiying Cheng, Balazs Halmos, Jeffrey Crawford, Jane Cerise, Martin Lesser
- Abstract
Loading...
-
+
P2.17 - Treatment of Locoregional Disease - NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.17-32 - Dynamic Monitoring Before and After Neo-Adjuvant Crizotinib in Non-Small Cell Lung Cancer: A Brief Report
16:45 - 18:00 | Presenter: Chao Zhang | Author(s): Ying Chen, Song Dong, Qiang Nie, Jin -Ji Yang, Xue-Ning Yang, Xu-Chao Zhang, Yi-Long Wu, Wen-Zhao Zhong
- Abstract
Loading...
-
+
OA13 - Therapeutics and Radiation for Small Cell Lung Cancer
- 10:30 - 12:00
- 9/26/2018
- Location: Room 203 BD
- Type: Oral Abstract Session
- Track: Small Cell Lung Cancer/NET
-
+
OA13.03 - Anlotinib as Third-Line or Further-Line Treatment in Relapsed SCLC: A Multicentre, Randomized, Double-Blind Phase 2 Trial
10:50 - 11:00 | Presenter: Ying Cheng | Author(s): Qiming Wang, Kai Li, Jianhua Shi, Lin Wu, Baohui Han, Gongyan Chen, Jianxing He, Jie Wang, Haifeng Qin, Xiaoling Li
- Abstract
Loading...